London-based Compass Pathways PLC, which has adopted the conventional biotech strategy of modifying naturally existing psilocybin into a patentable drug and taking it through clinical trials. The firm, founded in 2020, boasted a stock market value of $2 billion in November 2021, but its shares since have slumped 80 percent. Small Pharma, a small Canadian…
…important revelation can be found in DARPA’s report. On one hand they admit the therapeutic value of psychedelic substances, and on the other, they dismiss it due to the “side effects” they call “hallucination.” Reinventing the medicine wheel is not an attempt to revolutionize medicine, since the revolution has already happened in a prehistoric distant…
One challenge stands out: psilocybin seems to make people more liberal. Scientific reports associating psychedelic use and liberal values stretch back as far as 1971, and although these findings have been replicated more recently, a noncausal explanation is readily available. If psilocybin does change political values, the significance of this effect goes deeper than which…
Passing Measure 109, she said, would “set up Oregonians as really the guinea pigs to be receiving psilocybin treatment for psychological conditions with high rates of morbidity and mortality if treated quickly or left untreated.” The leader of the Oregon Psychiatric Physician Association told The Lund Report the group opposes the measure, as does American…
…no stranger to the psychedelic scene having collaborated with Timothy Leary, Robert Anton Wilson, Terence McKenna, Ralph Metzner, Mark Pesce, and Erik Davis. …the mental health epidemic as an externality of capitalism, and placing our trust in… cures [that generate profits at the expense of individual and natural rights]. Will [the current pandemic] be to…
New research recently published in Psychopharmacology provides evidence that inert placebo pills can induce psychedelic-like effects, including perceptual alterations. The findings highlight the importance of expectations and context when ingesting psychedelic substances. The researchers told the participants they were being given iprocin – a homologue of psilocybin, the active ingredient in psychedelic mushrooms – and that they…
“A very special tattoo – actually my first one ever – for a very special day…” -[said Christian Angermayer]… “Palantir is going public, meaning they will be able to make money on Wall Street while working [with] ICE,” MSC wrote in a tweet. Many of the outside backers that Angermayer brought into Compass are also…
COMPASS patent… compared to proprietary insulin formulations and asthma inhalers created to increase corporate profits… will share similar issues to “big pharma, big tech, big ag [agriculture], and other monopoly-heavy industries.” COMPASS’s attempt to dismiss the dispute against their patent… “Although Patent Owner does not address the substance of Petitioner’s challenge, after considering the arguments…
The London-based firm filed to raise US$100 million, a placeholder amount likely to change, according to a filing Friday [8/28/2020] with the U.S. Securities and Exchange Commission. …has seen a renaissance in recent years in the scientific community. Scientists can’t exactly explain why psychedelics appear to help patients. Emerging brain-scanning technology suggests the substances can…
After waiting more than three months for a response, Canada’s Minister of Health Patty Hajdu finally granted exemptions to four patients, marking the first legal exemption for psilocybin ( use, outside of a clinical trial, since the substance was deemed illegal in 1974. “We would like to extend our incredible gratitude to the Honorable Minister…
Recent Comments